Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors.
Osipiuk, J., Azizi, S.A., Dvorkin, S., Endres, M., Jedrzejczak, R., Jones, K.A., Kang, S., Kathayat, R.S., Kim, Y., Lisnyak, V.G., Maki, S.L., Nicolaescu, V., Taylor, C.A., Tesar, C., Zhang, Y.A., Zhou, Z., Randall, G., Michalska, K., Snyder, S.A., Dickinson, B.C., Joachimiak, A.(2021) Nat Commun 12: 743-743
- PubMed: 33531496 
- DOI: 10.1038/s41467-021-21060-3
- Primary Citation of Related Structures:  
6WRH, 6WZU, 6XG3, 7JIR, 7JIT, 7JIV, 7JIW - PubMed Abstract: 
The pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to expand. Papain-like protease (PLpro) is one of two SARS-CoV-2 proteases potentially targetable with antivirals. PLpro is an attractive target because it plays an essential role in cleavage and maturation of viral polyproteins, assembly of the replicase-transcriptase complex, and disruption of host responses ...